{"id":"https://openalex.org/W2000648009","doi":"https://doi.org/10.1158/1538-7445.am2011-lb-208","title":"Abstract LB-208: Hijacking the PI3K/mTor and KRas/MEK/ERK signaling pathways with a therapeutic assault results in robust antitumor activity in PI3K/KRas and KRas mutant tumors","display_name":"Abstract LB-208: Hijacking the PI3K/mTor and KRas/MEK/ERK signaling pathways with a therapeutic assault results in robust antitumor activity in PI3K/KRas and KRas mutant tumors","alternate_titles":[],"publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W2000648009","doi":"https://doi.org/10.1158/1538-7445.am2011-lb-208","mag":"2000648009"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2011-lb-208","doi":"https://doi.org/10.1158/1538-7445.am2011-lb-208","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-lb-208","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000648009"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Loic Vincent1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Loic Vincent1","raw_affiliation_strings":["11sanofi-aventis Oncology, Vitry sur Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11sanofi-aventis Oncology, Vitry sur Seine, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109111401","display_name":"Anne Thomas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anne Thomas1","raw_affiliation_strings":["11sanofi-aventis Oncology, Vitry sur Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11sanofi-aventis Oncology, Vitry sur Seine, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100962170","display_name":"Jianguo Ma","orcid":"https://orcid.org/0009-0007-5184-7550","observed_orcids":["https://orcid.org/0009-0007-5184-7550"]},"institutions":[{"id":"https://openalex.org/I4210111614","display_name":"EMD Serono, Inc. (United States)","ror":"https://ror.org/027zrs220","country_code":"US","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210111614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jianguo Ma2","raw_affiliation_strings":["22TA Oncology, EMD Serono, Inc., Billerica, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"22TA Oncology, EMD Serono, Inc., Billerica, MA","institution_ids":["https://openalex.org/I4210111614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065197387","display_name":"Anderson Clark","orcid":"https://orcid.org/0009-0004-4246-5874","observed_orcids":["https://orcid.org/0009-0004-4246-5874"]},"institutions":[{"id":"https://openalex.org/I4210111614","display_name":"EMD Serono, Inc. (United States)","ror":"https://ror.org/027zrs220","country_code":"US","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210111614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anderson Clark2","raw_affiliation_strings":["22TA Oncology, EMD Serono, Inc., Billerica, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"22TA Oncology, EMD Serono, Inc., Billerica, MA","institution_ids":["https://openalex.org/I4210111614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045381285","display_name":"Jamie V. Shaw","orcid":"https://orcid.org/0000-0001-5131-7639","observed_orcids":["https://orcid.org/0000-0001-5131-7639"]},"institutions":[{"id":"https://openalex.org/I4210111614","display_name":"EMD Serono, Inc. (United States)","ror":"https://ror.org/027zrs220","country_code":"US","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210111614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jamie Shaw2","raw_affiliation_strings":["22TA Oncology, EMD Serono, Inc., Billerica, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"22TA Oncology, EMD Serono, Inc., Billerica, MA","institution_ids":["https://openalex.org/I4210111614"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ste\u0301phane Gue\u0301rif1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ste\u0301phane Gue\u0301rif1","raw_affiliation_strings":["11sanofi-aventis Oncology, Vitry sur Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11sanofi-aventis Oncology, Vitry sur Seine, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032887436","display_name":"Coumaran \u00c9gile","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Coumaran Egile1","raw_affiliation_strings":["11sanofi-aventis Oncology, Vitry sur Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11sanofi-aventis Oncology, Vitry sur Seine, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011428941","display_name":"Joanne J. Lager","orcid":"https://orcid.org/0000-0001-9104-1040","observed_orcids":["https://orcid.org/0000-0001-9104-1040"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Joanne Lager1","raw_affiliation_strings":["11sanofi-aventis Oncology, Vitry sur Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11sanofi-aventis Oncology, Vitry sur Seine, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052089394","display_name":"Laurent Deb\u00fcssche","orcid":"https://orcid.org/0000-0001-8025-0584","observed_orcids":["https://orcid.org/0000-0001-8025-0584"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laurent Debussche1","raw_affiliation_strings":["11sanofi-aventis Oncology, Vitry sur Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11sanofi-aventis Oncology, Vitry sur Seine, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020235332","display_name":"Christoph Lengauer","orcid":"https://orcid.org/0000-0002-4498-7228","observed_orcids":["https://orcid.org/0000-0002-4498-7228"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christoph Lengauer1","raw_affiliation_strings":["11sanofi-aventis Oncology, Vitry sur Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11sanofi-aventis Oncology, Vitry sur Seine, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006321055","display_name":"Carlos Garc\u00eda-Echeverr\u00eda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Carlos Garcia-Echeverria1","raw_affiliation_strings":["11sanofi-aventis Oncology, Vitry sur Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11sanofi-aventis Oncology, Vitry sur Seine, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079155002","display_name":"Janet Ogden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111614","display_name":"EMD Serono, Inc. (United States)","ror":"https://ror.org/027zrs220","country_code":"US","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210111614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janet A. Ogden2","raw_affiliation_strings":["22TA Oncology, EMD Serono, Inc., Billerica, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"22TA Oncology, EMD Serono, Inc., Billerica, MA","institution_ids":["https://openalex.org/I4210111614"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"71","issue":"8_Supplement","first_page":"LB","last_page":"208"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.8799999952316284},{"id":"https://openalex.org/keywords/ras-mapk-pathway","display_name":"RAS/MAPK pathway","score":0.9020000100135803},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.6510000228881836},{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.7620000243186951},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.7570000290870667},{"id":"https://openalex.org/keywords/pan-pi3k-inhibitor","display_name":"pan-PI3K inhibitor","score":0.8949999809265137},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6729999780654907},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7760000228881836},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.7720000147819519},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9800000190734863},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.753000020980835},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.6079999804496765}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.9370284080505371},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.8216607570648193},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6246184706687927},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.6182225942611694},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.5798161029815674},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5384743809700012},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44835031032562256},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.3202815055847168},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3152921497821808},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.291767954826355},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2772539258003235},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.23290053009986877},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19727131724357605},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2011-lb-208","doi":"https://doi.org/10.1158/1538-7445.am2011-lb-208","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-lb-208","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2328334748","https://openalex.org/W2041930762","https://openalex.org/W2039924299","https://openalex.org/W2047946511","https://openalex.org/W2330446675","https://openalex.org/W2082167659","https://openalex.org/W1592490241","https://openalex.org/W2096218887","https://openalex.org/W2766580713","https://openalex.org/W2120492882"],"abstract_inverted_index":{"Abstract":[0],"The":[1,378],"PI3K/AKT/mTOR":[2],"and":[3,8,17,34,47,77,114,134,138,157,166,207,212,259,274,321,351],"Ras/Raf/MEK/ERK":[4],"are":[5],"interlinked":[6],"growth":[7,190],"survival":[9],"signaling":[10],"pathways":[11],"both":[12,135,331],"involving":[13],"regulation":[14],"by":[15,306],"Ras":[16,33],"often":[18],"constitutively":[19],"activated":[20],"in":[21,30,58,73,75,78,89,95,110,129,167,169,194,332,343,372,389],"human":[22,170,347],"tumors":[23],"as":[24,56,142,163,220,278,340,342],"a":[25,96,215,266,333,365],"result":[26],"of":[27,43,51,87,98,154,196,210,233,316,336,346,368,386,400,405],"frequent":[28],"mutations":[29,128],"p1":[31,131,136],"10\u03b1,":[32,132],"BRaf.":[35],"Here,":[36],"we":[37],"have":[38],"assessed":[39],"the":[40,44,84,147,197,208,234,294,300,307,313,317,322,360,373,384,401,406],"antitumor":[41,231,369],"activity":[42,219,296],"oral,":[45],"potent":[46],"selective":[48],"allosteric":[49],"inhibitor":[50,319,325,362],"MEK1/2,":[52],"MSC1936369":[53,88,211,254,320],"(formerly":[54],"known":[55],"AS703026),":[57],"combination":[59,90,106,168,209,235,314,357],"with":[60,91,236,253,270,299,359],"SAR245408":[61,156,237,258,363],"(pan-PI3K":[62],"formerly":[63,70],"named":[64,71],"XL147)":[65],"or":[66,290],"SAR245409":[67,92,158,213,260,326],"(dual":[68],"panPI3K/mTOR":[69,324],"XL765)":[72],"cellular":[74],"vitro":[76],"vivo":[79],"xenograft":[80,172,344],"settings.":[81,391],"In":[82,149,184,244,355],"vitro,":[83],"anti-proliferative":[85],"effects":[86,107],"were":[93,108,140,159,261],"evaluated":[94],"panel":[97],"81":[99],"tumor":[100,125,171,189,268,303,329],"cell":[101,338],"lines":[102,339],"(17":[103],"indications).":[104],"Potent":[105],"seen":[109],"colorectal,":[111],"pancreatic,":[112],"breast":[113],"NSCL":[115],"cancers":[116],"when":[117],"compared":[118,203,221,279],"to":[119,146,200,204,222,280],"each":[120],"agent":[121,224,251],"alone.":[122],"Across":[123],"indications,":[124],"cells":[126],"harboring":[127],"KRas,":[130],"BRaf":[133],"10\u03b1":[137],"KRas":[139,301],"identified":[141],"those":[143],"more":[144],"sensitive":[145],"combination.":[148],"vivo,":[150],"suboptimal":[151],"therapeutic":[152,276],"doses":[153],"MSC1936369,":[155],"tested":[160],"PO":[161],"daily":[162],"single":[164,223,250,281],"agents":[165,282],"models:":[173],"MiaPaCa-2":[174,187],"pancreatic":[175],"carcinoma":[176],"(KRas":[177,288,349],"mut),":[178,293],"HCT116":[179],"colorectal":[180],"adenocarcinoma":[181],"(KRas/PIKC3A":[182],"mut).":[183,354],"animals":[185,245],"bearing":[186,246],"xenografts,":[188,249],"inhibition":[191,330],"was":[192,241,255,297],"observed":[193],"all":[195],"treatment":[198,315],"groups,":[199],"varying":[201],"degrees,":[202],"vehicle":[205],"(p<0.05)":[206],"induced":[214,265],"significantly":[216],"enhanced":[217,230,328],"anti-tumor":[218],"therapies.":[225],"A":[226],"trend":[227],"for":[228,409],"an":[229],"effect":[232],"also":[238],"emerged":[239],"but":[240],"not":[242],"significant.":[243],"HCT":[247],"116":[248],"therapy":[252,358],"active,":[256],"whereas":[257],"inactive.":[262],"Combination":[263],"treatments":[264],"sustained":[267],"stasis":[269],"several":[271],"partial":[272],"regressions":[273],"demonstrated":[275,364],"synergy":[277],"(p<0.05).":[283],"Using":[284],"primary":[285],"colon":[286],"xenografts":[287],"mut":[289,350],"dual":[291,308,323,352,374],"KRas/PIKC3A":[292,309],"greatest":[295],"achieved":[298],"mutated":[302,310],"model":[304],"followed":[305],"tumor.":[311],"Overall,":[312],"MEK":[318],"showed":[327],"large":[334],"battery":[335],"tumor-derived":[337],"well":[341],"models":[345],"cancer":[348],"PI3K/KRas":[353,375],"addition,":[356],"panPI3K":[361],"robust":[366],"gain":[367],"activity,":[370],"particularly":[371],"mutant":[376],"tumors.":[377],"available":[379],"preclinical":[380],"pharmacological":[381],"data":[382],"support":[383],"use":[385],"these":[387],"combinations":[388],"clinical":[390],"Citation":[392],"Format:":[393],"{Authors}.":[394],"{Abstract":[395],"title}":[396],"[abstract].":[397],"In:":[398],"Proceedings":[399],"102nd":[402],"Annual":[403],"Meeting":[404],"American":[407],"Association":[408],"Cancer":[410,420],"Research;":[411],"2011":[412],"Apr":[413],"2-6;":[414],"Orlando,":[415],"FL.":[416],"Philadelphia":[417],"(PA):":[418],"AACR;":[419],"Res":[421],"2011;71(8":[422],"Suppl):Abstract":[423],"nr":[424],"LB-208.":[425],"doi:10.1158/1538-7445.AM2011-LB-208":[426]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000648009","counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}
